To validate this approach, we performed TAILS in the ALT-positive osteosarcoma cell line U2OS using 3 pooled sgRNA oligos against non-targeting sequences (sgCtrl), the Bloom DNA helicase (sgBLM), and the DNA helicase FANCM (sgFANCM). The gene discussed is GPT; the disease is osteosarcoma.